News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Bard1 Life Sciences.
RELATED STOCKHEAD STORIES
News
Market highlights and 5 ASX small caps to watch on Tuesday
Experts
ScoPo’s powerplays: It’s been a rollercoaster ride, but take a look at Neuren
News
Trading Places: Investors are still pouring money into these recent ASX IPOs
News
February ASX Winners: A commodities boom, BNPL mania, and one tiny 10-bagger casino
Health & Biotech
BARD1 founders sue company over performance rights
Experts
ScoPo’s health powerplays: ‘A great start to reporting season for healthcare’
Health & Biotech
Check Up: Bard1 leads healthcare space as shares rise 470% in 2 weeks
News
10 at 10: These ASX stocks have the most onlookers this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Cancer diagnostics stock Bard1 gains another 40pc with more positive data
News
10 at 10: These ASX stocks are the market’s spark this morning
News
Weekly ASX Small Cap Wrap: Global stocks near $110 trillion in value
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
Last Orders: The ASX has finished in the red with small caps lagging
News
ASX Small Cap Lunch Wrap: Who’s takin’ it easy today?
Health & Biotech
Bard1 Life Sciences shares double after ovarian cancer detection tech passes test with flying colours
News
